Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
about
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - biomedical preventionHSV-2: in pursuit of a vaccineGenital ulcer disease treatment for reducing sexual acquisition of HIVPopulation-based biomedical sexually transmitted infection control interventions for reducing HIV infectionOral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patientsImmune modulation during latent herpesvirus infectionInfectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventionsHIV-1 prevention for HIV-1 serodiscordant couplesBehavioral and biomedical combination strategies for HIV preventionA systematic review and meta-analysis of risk factors for sexual transmission of HIV in IndiaA macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacyHSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV InfectionHSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York CityHIV-prevention science at a crossroads: advances in reducing sexual risk.Setting the stage: current state of affairs and major challenges.Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations.Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: Analyses from the Rakai trials.Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trialCharacteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India.Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers.New concepts in understanding genital herpes.A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Prevalence, incidence and correlates of HSV-2 infection in an HIV incidence adolescent and adult cohort study in western KenyaExamining the promise of HIV elimination by 'test and treat' in hyperendemic settings.Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2Rethinking the role of the local community in HIV epidemic spread in sub-Saharan Africa: a proximate-determinants approach.The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.Correlates of HIV-1 genital shedding in Tanzanian women.Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study.Methodologies for evaluating HIV prevention intervention (populations and epidemiologic settings)Contribution of sexually transmitted infections to the sexual transmission of HIV.Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India.Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register.Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation.Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa
P2860
Q21144588-ABF07323-7BFA-41DC-B14F-CC972ED414A5Q21198769-622D4AA5-74D1-4493-932D-A0ED4B7EB5C5Q22306291-BF2CC1BD-99DC-4EE0-ADD4-C664210A7FAAQ24201630-7C7E34BE-5EC1-4AED-8DE8-40333F916964Q24235716-7C9C67AB-9D05-4710-8D25-50A39AF16BE4Q24236379-A759F448-96A6-4C8C-8A3D-7ADCEF2122D5Q24624044-4284E939-094C-42CF-BD92-7D7554885F68Q26823594-41FA79B8-69B9-491D-938E-C3007F64C72AQ26996011-2D92AD25-AB2F-4223-B9BC-5BDC91207DDCQ27001172-63B0AF03-CC9D-4A95-A454-EF562D8C6E9BQ27025229-7A29478F-A141-4CD5-9851-B7630278CAB1Q27335068-286D9CA7-B7A4-4835-83B4-E0EA975BB08AQ28534118-9277B8EF-9E53-4DFA-8513-7ED81E39BF9DQ28539412-BC047156-7D59-4CBA-A73C-8C2505351AFCQ30378142-719E7852-AD42-4BD6-A879-6686E4E6B45DQ30388160-2F452995-0B4E-4EEC-BC11-E3CC9547A46FQ30401071-76840F6A-A104-4B4F-BF9F-FEA7B53D9346Q30912200-BDE668C7-BBC6-442C-9DA4-90578B61E390Q31028568-537664A5-DBF2-48FF-9F15-CD0AC60F81B1Q33378486-CDD2CF58-2BDD-4028-B7EF-50711514019CQ33436735-FCDF03CE-BBFA-413F-8013-BA21A9B3C51AQ33538879-DFA56D2B-1B52-4251-A126-C5B50CE3512EQ33550768-A3BA34C0-F690-46C0-B936-870009A2DE62Q33582145-007F5937-342D-4324-92EB-AE1005678CA9Q33609662-CE9C14C5-FE3A-4E8D-BD6E-B072261A97F2Q33769065-5E1A6C5C-6A10-4904-BFE0-EB5850348BB2Q33780939-13F96A5B-CD24-4783-9661-B4542118EEDFQ33797142-30515BD1-7DC0-44F0-BBA3-BB4A6B941716Q33812029-141EFB1A-7732-49F1-9090-8DF8C43F968AQ33822723-88993712-99A4-4B6F-B37B-BB44793F25E9Q33828458-F447CB64-C3B6-4B1F-A976-02E02AACAB8BQ33831737-B86815D3-4708-451D-B723-193CE06F7D92Q33842085-9B07E0A9-5091-437A-A2B0-2E97C1AA4CA4Q33851349-5B187543-F7F0-437F-8E1A-49C775142A29Q33904091-C9DA1D33-60CA-4063-BB52-C339915E63EFQ34071194-9DF61C72-A733-4545-B92B-396C005DA36DQ34082025-A2FCC0F7-ADF8-4B19-8FCA-B623D5D75DADQ34110332-8DF91B49-74A5-484E-AA1B-C9133D925485Q34123592-2CED390B-7E51-4C72-B808-851374848753Q34168214-98C83121-E837-4F13-9A9A-65A6F9007F70
P2860
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@en
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@nl
type
label
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@en
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@nl
prefLabel
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@en
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@nl
P2093
P2860
P50
P356
P1476
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
@en
P2093
David Ross
Dean Everett
Deborah Watson-Jones
HSV trial team
Helen A Weiss
Jerome Le Goff
Kathy Baisley
Kokugonza Mugeye
Laurent Belec
Louise Knight
P2860
P304
P356
10.1056/NEJMOA0800260
P407
P577
2008-03-12T00:00:00Z